Medistim ASA (LON:0OCD)

Market Cap	213.11M
Revenue (ttm)	39.10M
Net Income (ttm)	7.30M
Shares Out	n/a
EPS (ttm)	0.40
PE Ratio	29.19
Forward PE	n/a
Dividend	0.33 (0.20%)
Ex-Dividend Date	May 9, 2025

Volume	1,000
Average Volume	215
Open	160.50
Previous Close	165.50
Day's Range	160.50 - 160.50
52-Week Range	160.50 - 300.00
Beta	0.76
RSI	44.10
Earnings Date	Apr 8, 2025

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1984
• Employees: 154
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0OCD

Financial Performance

In 2024, Medistim ASA's revenue was 556.16 million, an increase of 6.73% compared to the previous year's 521.11 million. Earnings were 103.83 million, an increase of 0.01%.

Financial numbers in NOK